{
    "organizations": [],
    "uuid": "17fd8974ea20a79fb90e3bdf313355a0e7f68d58",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-initiator-pharma-completes-preclin/brief-initiator-pharma-completes-preclinical-studies-for-development-of-candidate-iped2015-idUSFWN1PH06N",
    "ord_in_thread": 0,
    "title": "BRIEF-Initiator Pharma Completes Preclinical Studies For Development Of Candidate IPED2015",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - INITIATOR PHARMA A/S:\n* SUCCESFULLY COMPLETES PRECLINICAL STUDIES FOR DEVELOPMENT OF CANDIDATE IPED2015\n* IT IS ANTICIPATED THAT IPED2015 WILL QUALIFY AS A CLINICAL CANDIDATE‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-22T15:50:00.000+02:00",
    "crawled": "2018-01-23T18:02:23.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "initiator",
        "pharma",
        "succesfully",
        "completes",
        "preclinical",
        "study",
        "development",
        "candidate",
        "iped2015",
        "anticipated",
        "iped2015",
        "qualify",
        "clinical",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}